Home
Scholarly Works
Phase II study of pegylated liposomal doxorubicin...
Conference

Phase II study of pegylated liposomal doxorubicin (Caelyx) in advanced hepatocellular carcinoma (HHC).

Authors

Ruff P; Moodley SD; Rapoport BL; Chasen MR; Jacobs C; Hacking D; Voroblof DA

Volume

11

Pagination

pp. 69-70

Publisher

KLUWER ACADEMIC PUBL

Publication Date

January 1, 2000

Conference proceedings

ANNALS OF ONCOLOGY

ISSN

0923-7534

Contact the Experts team